Combretastatin A-4 phosphate

Combretastatin A-4 phosphate
Systematic (IUPAC) name
Phosphoric acid mono-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenyl} ester
Identifiers
PubChem CID 5351387
ChemSpider 4508406
Synonyms CA4P; CA4PD; fosbretabulin; fosbretabulin disodium
Chemical data
Formula C18H21O8P
Molar mass 396.32 g/mol (exact mass : 396.097404)
  (verify)
For more information about this drug and its actions, see combretastatin.

Combretastatin A-4 phosphate (phosbretabulin, and its salt phosbretabulin disodium) is a microtubule destabilising drug, a type of vascular-targeting agent, a drug designed to damage the vasculature (blood vessels) of cancer tumours causing central necrosis. It is a derivative of combretastatin.

Combretastatin A-4 phosphate is a prodrug. In vivo, it is dephosphorylated to its active metabolite, combretastatin A-4.[1]

References


This article is issued from Wikipedia - version of the Saturday, April 16, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.